Dr. Jeffrey Keller from the Pennington Biomedical Institute joins the show to highlight a new collaboration with the ALS Foundation and Tulane University. The partnership focuses on developing innovative drug treatments for ALS (Amyotrophic Lateral Sclerosis). Dr. Keller emphasized the importance of combining research expertise and resources to accelerate progress in combating this debilitating disease, aiming to bring hope to patients and families affected by ALS through advanced scientific breakthroughs.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.